PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2015

Rapamycin Improves Mortality Following Intestinal Ischemia-Reperfusion via the Inhibition of Remote Lung Inflammation in Mice.

Mouse / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 26402062 ↗2015Reported benefit

Rapamycin Improves Mortality Following Intestinal Ischemia-Reperfusion via the Inhibition of Remote Lung Inflammation in Mice.

MouseIschaemia-reperfusionIntestinal / mesentericC57BL/6MaleIntraperitoneal injection5 mg/kg1 hour before ischaemia

Model: Intestinal ischaemia-reperfusion by occlusion of the superior mesenteric artery for 1 hour

Rapamycin improved survival after intestinal ischaemia-reperfusion. Intestinal injury and inflammation were similar between groups, but lung injury and inflammation were significantly attenuated, with reduced lung bacterial burden and increased alveolar macrophage phagocytic activity.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.